IGF1R and Hyperinsulinemia: Due to the homology and crosstalk between IGF-IR and IR, several inhibitors of IGF-IR signaling (including tyrosine kinase inhibitors) were found to also disrupt IR signaling, resulting in undesirable side effects such as hyperinsulinemia and hyperglycemia.